NASDAQ:JAGX - Jaguar Health Stock Price, Forecast & News

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

Jaguar Health Inc (NASDAQ:JAGX) issued its earnings results on Monday, November, 14th. The biotechnology company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.10. The biotechnology company had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. Jaguar Health had a negative return on equity of 675.03% and a negative net margin of 771.25%. View Jaguar Health's Earnings History.

Jaguar Health is scheduled to release their next quarterly earnings announcement on Wednesday, April 8th 2020. View Earnings Estimates for Jaguar Health.

2 Wall Street analysts have issued 1-year price objectives for Jaguar Health's shares. Their forecasts range from $3.00 to $5.00. On average, they expect Jaguar Health's stock price to reach $4.00 in the next year. This suggests a possible upside of 463.2% from the stock's current price. View Analyst Price Targets for Jaguar Health.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Jaguar Health.

Media coverage about JAGX stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Jaguar Health earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Jaguar Health.

Some companies that are related to Jaguar Health include Aravive (ARAV), Aldeyra Therapeutics (ALDX), IDEAYA Biosciences (IDYA), PhaseBio Pharmaceuticals (PHAS), Newron Pharmaceuticals (NWPHF), Corvus Pharmaceuticals (CRVS), Galmed Pharmaceuticals (GLMD), Cassava Sciences (SAVA), Menlo Therapeutics (MNLO), ProMetic Life Sciences (PFSCF), Xeris Pharmaceuticals (XERS), TapImmune (MRKR), Helix Biopharma (HBPCF), AcelRx Pharmaceuticals (ACRX) and Inflarx (IFRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biopharmx (BPMX), Conatus Pharmaceuticals (CNAT), Cara Therapeutics (CARA), Precipio (PRPO), Neovasc (NVCN), PTC Therapeutics (PTCT), Biocept (BIOC), Cascadian Therapeutics (CASC), Cellectar Biosciences (CLRB) and SCYNEXIS (SCYX).

(JAGX) raised $22 million in an initial public offering (IPO) on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

Jaguar Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.21%). Company insiders that own Jaguar Health stock include James J Bochnowski, Jonathan B Siegel, Lisa A Conte and Nantucket Investments Ltd. View Institutional Ownership Trends for Jaguar Health.

JAGX stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Jaguar Health stock in the last two years include James J Bochnowski, Jonathan B Siegel and Lisa A Conte. View Insider Buying and Selling for Jaguar Health.

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of JAGX stock can currently be purchased for approximately $0.71.

Jaguar Health has a market capitalization of $36.33 million and generates $4.42 million in revenue each year. The biotechnology company earns $-32,150,000.00 in net income (profit) each year or ($158.74) on an earnings per share basis. Jaguar Health employs 40 workers across the globe.View Additional Information About Jaguar Health.

The official website for Jaguar Health is http://www.jaguaranimalhealth.com/.

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at 415-371-8300.